Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: An observational database study

Pain

Volumn 157, Issue 7, 2016, Pages 1525-1531

  Bedson, John ^a   Chen, Ying ^a   Hayward, Richard A ^a   Ashworth, Julie ^a   Walters, Kate ^b   Dunn, Kate M ^a   Jordan, Kelvin P ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesic; Long term care; Musculoskeletal pain; Opioid; Prescriptions; Trends

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONSULTATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; CHRONIC PAIN; CLINICAL PRACTICE; FACTUAL DATABASE; MUSCULOSKELETAL PAIN; TRENDS; UNITED KINGDOM;

ANALGESICS, OPIOID; CHRONIC PAIN; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MUSCULOSKELETAL PAIN; PRACTICE PATTERNS, PHYSICIANS'; UNITED KINGDOM;

EID: 84976417361     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000557     Document Type: Article

References (46)

1. Bedson J, Belcher J, Martino OI, Ndlovu M, Rathod T, Walters K, Dunn KM, Jordan KP. The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: an observational database study. Eur J Pain 2013; 17: 434-43
2. BNF. British national formulary. London: BMJ Group, 2014
3. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-Term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18: 1166-75
4. Care Quality Commission. The safer management of controlled drugs, Annual report 2012. 2013. Available at: http://www.cqc.org.uk/sites/default/files/documents/cdar-2012.pdf. Accessed September 19, 2015
5. Chevalier P, Smulders M, Chavoshi S, Sostek M, LoCasale R. A description of clinical characteristics and treatment patterns observed within prescribed opioid users in Germany and the UK. Pain Manag 2014; 4: 267-76
6. Department of Health. Controlled drugs (supervision of management and use) regulations 2013. 2013. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/214915/15-02-2013-controlled-drugs-regulation-information.pdf. Accessed September 19, 2015
7. Department of Health (England) and the Devolved Administrations. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, 2007
8. Dowd A. Some PCTs recommend GPs limit prescriptions to 28 days. BMJ 2011; 342: d2410
9. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010; 152: 85-92
10. Edwards JJ, Jordan KP, Peat G, Bedson J, Croft PR, Hay EM, Dziedzic KS. Quality of care for OA: the effect of a point-of-care consultation recording template. Oxford: Anonymous Rheumatology, 2014
11. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating the average annual percent change for disease rates without assuming constant change. Biometrics 2006; 62: 847-54
12. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-Analysis of effectiveness and side effects. CMAJ 2006; 174: 1589-94
13. Gallagher AM, Puri S, Van Staa T. Linkage of theGeneral Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf 2011; 20: S230-231
14. Green DJ, Bedson J, Blagojevic-Burwell M, Jordan KP, van der Windt D. Factors associated with primary care prescription of opioids for joint pain. Eur J Pain 2013; 17: 234-44
15. Gregory S. General practice in England: an overview. The King?s Fund, 2009. Available at: http://www.kingsfund.org.uk/sites/files/kf/generalpractice-in-england-overview-sarah-gregory-kings-fund-september-2009.pdf. Accessed November 27, 2015
16. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and wellbeing: a World Health Organization Study in Primary Care. JAMA 1998; 280: 147-51
17. Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009; 13: 954-62
18. Health and Social Care Information Centre. Numbers of patients registered at a GP practice-April 2014. 2014. Available at: http://www.hscic.gov.uk/catalogue/PUB13932. Accessed November 27, 2015
19. Health and Social Care Information Centre.Read codes. 2015. Available at: http://systems.hscic.gov.uk/data/uktc/readcodes. Accessed September 19, 2015
20. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2009; 69: 4-14
21. Jordan K, Kadam U, Hayward R, Porcheret M, Young C, Croft P. Annual consultation prevalence of regional musculoskeletal problems in primary care. BMC Musculoskelet Disord 2010; 11: 144
22. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51
23. Lanza F, Chan F, Quigley E. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009; 104: 728-38
24. Lawson D, Sherman V, Hollowell J. The general practice research database. Q J Med 1998; 91: 445-52
25. Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CWC, Day RO, McLachlan AJ, Ferreira ML. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-Analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225
26. Manchikanti L, Fellows B, Ailinani H, Pamapti P. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Phys 2010; 13: 401-35
27. Muller S, Bedson J, Mallen CD. The association between pain intensity and the prescription of analgesics and non-steroidal anti-inflammatory drugs. Eur J Pain 2012; 16: 1014-20
28. National Cancer Institute. Joinpoint regression program. 2015. Available at: http://surveillance.cancer.gov/joinpoint/. Accessed September 19, 2015
29. Ndlovu M, Bedson J, Jones PW, Jordan KP. Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data. BMC Musculoskelet Disord 2014; 15: 1-11
30. NICE. Osteoarthritis care and management in adults: NICE clinical guideline 177. 2014. Available at: http://www.nice.org.uk/nicemedia/live/14383/66527/66527.pdf. Accessed September 16, 2015
31. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-Term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; 1: CD006605
32. Office of National Drug Control Policy. Epidemic: responding to America?s prescription drug abuse crisis. 2011. Available at: http://www. whitehouse.gov/sites/default/files/ondcp/issues-content/prescriptiondrugs/rx-Abuse-plan.pdf. Accessed September 19, 2015
33. ONS. Mid-year population estimates for the UK 2014. 2015. Available at: http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-foruk-england-And-wales-scotland-And-northern-ireland/mid-2014/midyear-population-estimates-for-The-uk-2014.html. Accessed November 27, 2015
34. Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. PAIN 2008; 138: 507-13
35. Prescribing and Medicines Team Health and Social Care Information Centre. Prescriptions dispensed in the community England 2004-14. 2015. Available at: http://www.hscic.gov.uk/catalogue/PUB17644/presdisp-com-eng-2004-14-rep.pdf. Accessed April 4, 2016
36. Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain 2015; 19: 59-66
37. Saunders K, Dunn KM, Merrill J, Sullivan MD, Weisner C, Brennan Braden J, Psaty BM, Von Korff M. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. JGen Intern Med 2010; 4: 310-15
38. Smith BH, Torrance N. Epidemiology of neuropathic pain. Pain Manag 2011; 1: 87-96
39. Stannard C. Opioid prescribing in the UK: can we avert a public health disaster? Br J Pain 2012; 6: 7-8
40. Tate AR, Beloff N, Al-Radwan B, Wickson J, Puri S, Williams T, Van Staa T, Bleach A. Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface. J Am Med Inform Assoc 2014; 21: 292-8
41. The Advisory Council on the Misuse of Drugs. Misuse of drugs act 1971. 1971. Available at: http://www.legislation.gov.uk/ukpga/1971/38/pdfs/ukpga-9710038-en.pdf. Accessed September 19, 2015
42. UK Statutory Instruments. The misuse of drugs regulations. 2001. Available at: http://www.legislation.gov.uk/uksi/2001/3998/made. Accessed September 19, 2015
43. Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C. De facto long-Term opioid therapy for noncancer pain. Clin J Pain 2008; 24: 521-7
44. WHO. Daily defined dose: definition and general considerations. 2014. Available at: http://www.whocc.no//definition-And-general-considera/. Accessed September 19, 2015
45. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012; 3: 89-99
46. Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain 2014; 18: 1343-51